日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

PARP inhibition with olaparib and talazoparib for HER2-negative advanced breast cancer-Results from the prospective PRAEGNANT registry

使用奥拉帕尼和他拉唑帕尼抑制PARP活性治疗HER2阴性晚期乳腺癌——来自前瞻性PRAEGNANT注册研究的结果

Hörner, Manuel; Hartkopf, Andreas; John, Nelson; Ziegler, Philipp; Häberle, Lothar; Uhrig, Sabrina; Goossens, Chloë; Amann, Niklas; Cieslik, Jan-Philipp; Tretschock, Lara M; Dannehl, Dominik; Deutsch, Thomas M; Dimpfl, Moritz; Ehlert, Max; Eichstädt, Kathleen; Englisch, Alexander; Köpke, Melitta B; Krückel, Annika; Link, Theresa; Müller, Annika; Reinhardt, Kristin; Roth, Jonas; Schäffler, Henning; Sych, Lea; Tauber, Nikolas; Tegeler, Christian M; Wichmann, Catharina; Banys-Paluchowski, Maggie; Princk, Henriette; Rody, Achim; Brucker, Sara Y; Ditsch, Nina; Ettl, Johannes; Fehm, Tanja; Hack, Carolin C; Hadji, Peyman; Hein, Alexander; Janni, Wolfgang W; Kolberg, Hans-Christian; Lüftner, Diana; Lux, Michael P; Müller, Volkmar; Taran, Florin-Andrei; Tesch, Hans; Wallwiener, Diethelm; Marmé, Frederik; Seitz, Stephan; Belleville, Erik; Michel, Laura L; Wallwiener, Markus; Fasching, Peter A; Schneeweiss, Andreas; Maurer, Christian

Medical education in obstetrics and gynecology: A global update from 2025

妇产科医学教育:2025 年全球展望

Recker, Florian; Neubauer, Ricarda; Adams, Jana; Ludwig, Sebastian; Taran, Florin-Andrei; Groten, Tanja

Alpelisib and Fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the German PRAEGNANT trial

在德国PRAEGNANT试验中,Alpelisib和Fulvestrant被用于治疗PIK3CA突变、激素受体阳性、HER2阴性的晚期乳腺癌。

Hörner, Manuel; Tretschock, Lara M; John, Nelson; Ziegler, Philipp; Häberle, Lothar; Uhrig, Sabrina; Goossens, Chloë; Amann, Niklas; Cieslik, Jan-Philipp; Dannehl, Dominik; Deutsch, Thomas M; Dimpfl, Moritz; Ehlert, Max; Eichstädt, Kathleen; Englisch, Alexander; Köpke, Melitta B; Krückel, Annika; Link, Theresa; Müller, Annika; Reinhardt, Kristin; Roth, Jonas; Schäffler, Henning; Sych, Lea; Tegeler, Christian M; Wichmann, Catharina; Banys-Paluchowski, Maggie; Princk, Henriette; Rody, Achim; Brucker, Sara Y; Ditsch, Nina; Ettl, Johannes; Fehm, Tanja; Hack, Carolin C; Hadji, Peyman; Hein, Alexander; Janni, Wolfgang W; Kolberg, Hans-Christian; Lüftner, Diana; Lux, Michael P; Müller, Volkmar; Schneeweiss, Andreas; Taran, Florin-Andrei; Tesch, Hans; Wallwiener, Diethelm; Marmé, Frederik; Seitz, Stephan; Belleville, Erik; Hartkopf, Andreas; Michel, Laura L; Wallwiener, Markus; Fasching, Peter A; Tauber, Nikolas

Learning curves, safety, and experiences of a tertiary surgical center in the introduction of robotic-assisted surgery in gynecologic oncology

妇科肿瘤机器人辅助手术引入过程中的学习曲线、安全性和经验——一家三级外科中心的经验

Jung, Lisa; Taran, Florin-Andrei; Huwer, Sarah; Kurz, Benedikt; Klar, Maximilian; Favre-Inhofer, Angeline; Juhasz-Böss, Ingolf

Choriocarcinoma: Navigating risk, resistance, and remarkable curability

绒毛膜癌:风险、耐药性和卓越的治愈率

Dannehl, Dominik; Taran, Florin-Andrei

Can Ki-67 serve as a suitable marker to indicate the necessity of staging diagnostics in cases of low-risk breast cancer?

Ki-67 能否作为低风险乳腺癌病例中判断是否需要进行分期诊断的合适标志物?

Jung, Lisa; Huwer, Sarah Isabelle; Jungmann, Peter; Medl, Markus; Taran, Florin-Andrei; Neubauer, Jakob; Wilpert, Carolin; Juhasz-Böss, Ingolf; Müller, Carolin

Clinical routine care for choriocarcinoma: a descriptive analysis of data from the Baden-Wuerttemberg Cancer Registry (BWCR)

绒毛膜癌的临床常规护理:巴登-符腾堡州癌症登记处(BWCR)数据的描述性分析

Taran, Florin-Andrei; Wosnik, Annette; Juhasz-Böss, Ingolf; Burtscher, Katrin; Morakis, Philipp

Impact of adjuvant endocrine therapy utilization in male patients with early breast cancer: results from a large German real-world claims data analysis

辅助内分泌治疗对早期乳腺癌男性患者的影响:一项基于德国大型真实世界索赔数据分析的研究结果

Dannehl, Dominik; Dijkstra, Tjeerd Maarten Hein; von Au, Alexandra; Scholz, Anna Sophie; Volmer, Léa Louise; Hahn, Markus; Hawighorst-Knapstein, Sabine; Chaudhuri, Ariane; Taran, Florin-Andrei; Wallwiener, Markus; Bauer, Armin; Wallwiener, Diethelm; Brucker, Sara Yvonne; Wallwiener, Stephanie; Hartkopf, Andreas; Engler, Tobias

Update Breast Cancer 2024 Part 2 - Patients with Early Stage Breast Cancer

2024年乳腺癌最新进展(第二部分)——早期乳腺癌患者

Janni, Wolfgang; Kolberg, Hans-Christian; Hartkopf, Andreas D; Fehm, Tanja N; Welslau, Manfred; Müller, Volkmar; Schütz, Florian; Fasching, Peter A; Jackisch, Christian; Marme, Frederik; Hörner, Manuel; Keller, Katharina; Goossens, Chloë; Belleville, Erik; Untch, Michael; Thill, Marc; Tesch, Hans; Ditsch, Nina; Lux, Michael P; Banys-Paluchowski, Maggie; Wöckel, Achim; Harbeck, Nadia; Stickeler, Elmar; Bartsch, Rupert; Aktas, Bahriye; Schneeweiss, Andreas; Ettl, Johannes; Taran, Florin-Andrei; Lüftner, Diana; Würstlein, Rachel; Radosa, Julia C

Update Breast Cancer 2024 Part 3 - Patients with Advanced Stage Breast Cancer

2024年乳腺癌最新进展(第三部分)——晚期乳腺癌患者

Lüftner, Diana; Kolberg, Hans-Christian; Hartkopf, Andreas D; Fehm, Tanja N; Welslau, Manfred; Müller, Volkmar; Schütz, Florian; Fasching, Peter A; Jackisch, Christian; Marme, Frederik; Keller, Katharina; Hörner, Manuel; Goossens, Chloë; Belleville, Erik; Untch, Michael; Thill, Marc; Tesch, Hans; Ditsch, Nina; Radosa, Julia C; Banys-Paluchowski, Maggie; Wöckel, Achim; Harbeck, Nadia; Stickeler, Elmar; Bartsch, Rupert; Aktas, Bahriye; Schneeweiss, Andreas; Ettl, Johannes; Taran, Florin-Andrei; Janni, Wolfgang; Würstlein, Rachel; Lux, Michael P